With antiviral therapy, the early cirrhotic process can be slowed and fibrosis of liver cells and tissues can be stopped, but an already hardened liver will not be reversed. Cirrhosis caused by viral infection can be treated with antiviral therapy to slow or stop fibrosis in the liver that has not yet developed hardening. Viral cirrhosis includes hepatitis B cirrhosis and hepatitis C cirrhosis. Hepatitis B viral cirrhosis can be treated with interferon injections and oral antiviral therapy with nucleotide analogs such as lamivudine, entecavir, adefovir, and telbivudine. For hepatitis C viral cirrhosis, oral direct antiviral small molecule drugs (DDA small molecule drugs) such as telaprevir, boceprevir, simeprevir, anaprevir, and other NS3/4 serine protease inhibitors and sofosbuvir, Dasabuvir, and other NS5B polymerase inhibitors are often used for antiviral treatment. It should be noted that all of the above drugs should be used under the guidance of a doctor and should not be used without authorization. Cirrhosis patients are advised to seek medical advice to clarify the diagnosis and carry out targeted treatment.